未登录

P

Ping Du

guoneng shendong coal geological survey company

H指数:18

被引数:835

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intelligent recognition method for drilling conditions of deep formation based on LSTM neural network

基于LSTM神经网络的深地层钻进条件智能识别方法

Discover Applied Sciences

IF2.4

2025-12-190

OAAI

The importance of the Autostrain RV technique in the treatment of right ventricular myocardial alterations in patients with breast cancer receiving chemotherapy

SCIENTIFIC REPORTS

IF3.9

2025-01-220

OAAI

The Modular and Integrated Data Assimilation System at Environment and Climate Change Canada (MIDAS v3.9.1)

GEOSCIENTIFIC MODEL DEVELOPMENT

IF4.9

2025-01-060

OA

The Core Circadian Clock Factor, Bmal1, Transduces Sex-specific Differences in Both Rhythmic and Nonrhythmic Gene Expression in the Mouse Heart

IF3.8

2024-12-101

OAAI

Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome - A sham-controlled, randomized, clinical trial

皮内针治疗肝肾亏虚型类风湿关节炎的随机对照临床试验

COMPLEMENTARY THERAPIES IN MEDICINE

IF3.5

2024-06-011

OAAI

Formaldehyde aggravates airway inflammation through induction of glycolysis in an experimental model of asthma exacerbated by lipopolysaccharide

SCIENCE OF THE TOTAL ENVIRONMENT

IF8

2024-02-017

PRE

Impact of NLRP3 gene polymorphisms (rs10754558 and rs10733113) on HPV infection and cervical cancer in southern Chinese population

INFECTIOUS AGENTS AND CANCER

IF2.8

2023-10-263

OAAI

The skeletal muscle circadian clock regulates titin splicing through RBM20

骨骼肌生物钟通过RBM20调节肌动蛋白剪接

IF0

2022-09-0110

OA

Integrative Analysis of Pharmacokinetic and Metabolomic Profiles for Predicting Metabolic Phenotype and Drug Exposure Caused by Sotorasib in Rats

FRONTIERS IN ONCOLOGY

IF3.3

2022-04-052

OAAI

Serum Eicosanoids Metabolomics Profile in a Mouse Model of Renal Cell Carcinoma: Predicting the Antitumor Efficacy of Anlotinib

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-02-092

OAAI

Development and validation of a robust and sensitive HPLC-MS/MS method for the quantitation of MRTX849 in plasma and its application in pharmacokinetics

IF3.3

2022-01-016

PRE

Quantitative HPLC-MS/MS determination of Nuc, the active metabolite of remdesivir, and its pharmacokinetics in rat

ANALYTICAL AND BIOANALYTICAL CHEMISTRY

IF3.8

2021-07-2423

OAAI

Dual derivatization strategy for the comprehensive quantification and double bond location characterization of fatty acids by ultra-high performance liquid chromatography-tandem mass spectrometry

JOURNAL OF CHROMATOGRAPHY A

IF4

2021-02-0115

PREAI

Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: Phenotype, Efficacy, and Toxicity

FRONTIERS IN ONCOLOGY

IF3.3

2020-11-1218

OAAI

Simultaneous quantitative determination of arachidonic acid and cascade metabolites in rat serum by UPLC-MS/MS: application for longitudinal metabolomics of anlotinib

IF3.3

2020-01-0113

PREAI

MYOD1 functions as a clock amplifier as well as a critical co-factor for downstream circadian gene expression in muscle

IF0

2019-02-2161

OA

A selective and robust UPLC-MS/MS method for the simultaneous quantitative determination of anlotinib, ceritinib and ibrutinib in rat plasma and its application to a pharmacokinetic study

IF3.3

2019-01-0129

PREAI

A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia

CHINESE JOURNAL OF CANCER RESEARCH

IF6.3

2017-01-0113

OA

Development and validation of a UPLC-MS/MS assay for the quantification of simotinib in human plasma

ANALYTICAL AND BIOANALYTICAL CHEMISTRY

IF3.8

2014-01-106

PREAI

Oral topotecan: Bioavailability, pharmacokinetics and impact of ABCG2 genotyping in Chinese patients with advanced cancers

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2013-10-0110

PREAI